Description

Our client, a leading Chinese securities firm in Hong Kong, is seeking an Equity Research Analyst to cover the Healthcare sector, with a focus on Hong Kong-listed pharmaceutical companies. The ideal candidate will possess a hybrid background combining expertise in life sciences/medicine with strong financial analysis skills.

Key Responsibilities :

• Independently conduct in-depth research and analysis on Hong Kong-listed pharmaceutical enterprises, covering sub-sectors such as biotech, innovative pharmaceuticals, and healthcare services.
• Develop and maintain detailed financial models to evaluate company valuations, growth drivers, and risk exposures (e.g., regulatory approvals, patent cliffs).
• Produce high-quality, actionable research reports including thematic studies, company-specific updates, and sector reviews covering regulatory shifts, clinical trials, and product launches.
• Monitor and interpret global pharmaceutical industry trends (e.g., novel therapies, M&A, FDA/EMA regulations) and assess their impact on Hong Kong-listed equities.
• Engage with internal teams (especially mainland China-based pharmaceutical analysts) to align research views, share insights on cross-border trends, and ensure cohesive cross-market analysis.
• Communicate investment recommendations effectively through written reports, client meetings, and formal presentations tailored to both financial and non-financial audiences.
• Attend industry conferences, conduct company site visits, and network with key opinion leaders (e.g., clinicians, consultants) to enhance sector expertise.

Requirements

• Master's or higher in Life Sciences (Biochemistry, Microbiology, etc.), Medicine, Pharmacy, Finance, or Economics. Advanced degrees (PhD, MBA) or professional certifications (CFA, FRM) are strongly preferred.
• Minimum 2 years of sell-side equity research experience focusing on the healthcare/pharmaceutical sector; familiarity with Hong Kong markets and HKEX regulations is a significant advantage.
• Demonstrated ability to independently manage sector coverage, generate investment ideas, and support decision-making through rigorous analysis.
• Proficiency in translating complex scientific/medical data (e.g., clinical trial results) into investable insights.
• Strong financial modeling skills and familiarity with data analysis tools.
• Fluency in English and Mandarin (written and spoken); exceptional communication and presentation skills.

Ideal Profile

The successful candidate will be a proactive, detail-oriented analyst with a passion for the healthcare sector and the ability to work both independently and collaboratively within a cross-border team. Prior exposure to Hong Kong or Greater China equity markets is highly valued.